Browsing Bergen Open Research Archive by Author "Furu, Kari"

Now showing items 1-17 of 17

    • Antipsychotic drug use in pregnancy: A multinational study from ten countries 

      Reutfors, Johan; Cesta, Carolyn; Cohen, Jacqueline Mallory; Bateman, Brian T; Brauer, Ruth; Einarsdottir, Kristjana; Engeland, Anders; Furu, Kari; Gissler, Mika; Havard, Alys; Hernandez-Diaz, Sonia; Huybrechts, Krista F.; Karlstad, Øystein; Leinonen, Maarit; Li, Jiong; Man, Kenneth K. C.; Pazzagli, Laura; Schaffer, Andrea; Schink, Tania; Wang, Zixuan; Yu, Yongfu; Zoega, Helga; Bröms, Gabriella (Journal article; Peer reviewed, 2020)
      Aim To compare the prevalence and trends of antipsychotic drug use during pregnancy between countries across four continents. Methods Individually linked health data in Denmark (2000−2012), Finland (2005–2014), Iceland ...

    • Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study 

      Bruno, Claudia; Cesta, Carolyn E.; Hjellvik, Vidar; Ulrichsen, Sinna Pilgaard; Bjørk, Marte-Helene; Esen, Buket Öztürk; Gillies, Malcolm B.; Gissler, Mika; Havard, Alys; Karlstad, Øystein; Leinonen, Maarit; Nørgaard, Mette; Pearson, Sallie-Anne; Reutfors, Johan; Furu, Kari; Cohen, Jacqueline Mallory; Zoega, Helga (Journal article; Peer reviewed, 2024)
      Background Antipsychotics are commonly prescribed to treat a range of psychiatric conditions in women of reproductive age and during pregnancy, including schizophrenia, bipolar disorder, anxiety, depression, autism ...

    • Antipsychotic use in pregnancy and risk of attention/ deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study 

      Halfdanarson, Oskar; Cohen, Jacqueline Mallory; Karlstad, Øystein; Cesta, Carolyn E.; Bjørk, Marte-Helene; Håberg, Siri Eldevik; Einarsdottir, Kristjana; Furu, Kari; Gissler, Mika; Hjellvik, Vidar; Kieler, Helle; Leinonen, Maarit; Nørgaard, Mette; Essen, Buket Öztürk; Ulrichsen, Sinna Pilgaard; Reutfors, Johan; Zoega, Helga (Journal article; Peer reviewed, 2021)
      Background Antipsychotics are increasingly used among women of childbearing age and during pregnancy. Objective To determine whether children exposed to antipsychotics in utero are at increased risk of attention-d ...

    • Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study 

      Hartz, Ingeborg; Sakshaug, Solveig; Furu, Kari; Engeland, Anders; Eggen, Anne Elise; Njølstad, Inger; Skurtveit, Svetlana (Peer reviewed; Journal article, 2007-12-05)
      Background: The aim of this paper was to test the goodness of fit of the Attitude – Social influence – self-Efficacy (ASE) model in explaining schoolchildren's intentions to eat fruit and their actual fruit intake in ...

    • Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability 

      Bjørk, Marte-Helene; Zoega, Helga; Leinonen, Maarit K.; Cohen, Jacqueline Mallory; Dreier, Julie Werenberg; Furu, Kari; Gilhus, Nils Erik; Gissler, Mika; Halfdanarson, Oskar; Igland, Jannicke; Sun, Yuelian; Tomson, Torbjörn; Alvestad, Silje; Christensen, Jakob (Journal article; Peer reviewed, 2022)
      Importance: Women with epilepsy frequently need antiseizure medication (ASM) to prevent seizures in pregnancy. Risk of neurodevelopmental disorders after prenatal exposure to AMSs is uncertain. Objective: To determine ...

    • Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations: A Multinational Study 

      Bröms, Gabriella; Hernandez-Diaz, Sonia; Huybrechts, Krista F.; Bateman, Brian T.; Kristiansen, Eskild Bendix; Einarsdóttir, Kristjana; Engeland, Anders; Furu, Kari; Gissler, Mika; Karlsson, Pär; Klungsøyr, Kari; Lahesmaa-Korpinen, Anna-Maria; Mogun, Helen; Nørgaard, Mette; Reutfors, Johan; Sørensen, Henrik Toft; Zoega, Helga; Kieler, Helle (Journal article; Peer reviewed, 2023)
      Objective: Most research on safety of attention-deficit/ hyperactivity disorder (ADHD) medications during pregnancy concerns central nervous system stimulants, while little is known about the safety of atomoxetine, a primary ...

    • Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases 

      Instanes, Johanne Telnes; Halmøy, Anne; Engeland, Anders; Haavik, Jan; Furu, Kari; Klungsøyr, Kari (Peer reviewed; Journal article, 2017-03)
      Background: Prenatal inflammatory mechanisms may play a role in the pathogenesis of psychiatric disorders and could be relevant for attention-deficit/hyperactivity disorder (ADHD). We investigated maternal chronic somatic ...

    • Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy 

      Cohen, Jacqueline Mallory; Alvestad, Silje; Suarez, Elizabeth A.; Schaffer, Andrea; Selmer, Randi M.; Havard, Alys; Bateman, Brian T.; Cesta, Carolyn E.; Zoega, Helga; Odsbu, Ingvild; Huybrechts, Krista F.; Kjerpeseth, Lars J.; Straub, Loreen; Leinonen, Maarit K.; Bjørk, Marte-Helene; Nørgaard, Mette; Gissler, Mika; Ulrichsen, Sinna P.; Hernandez-Diaz, Sonia; Tomson, Torbjörn; Furu, Kari (Journal article; Peer reviewed, 2023)
      Background and Objectives Valproate should be avoided in pregnancy, but it is the most effective drug for generalized epilepsies. Alternative treatment may require combinations of other drugs. Our objectives were to ...

    • Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations 

      Cohen, Jacqueline Mallory; Alvestad, Silje; Cesta, Carolyn E.; Bjørk, Marte-Helene; Leinonen, Maarit; Nørgaard, Mette; Einarsdóttir, Kristjana; Engeland, Anders; Gissler, Mika; Karlstad, Øystein; Klungsøyr, Kari; Odsbu, Ingvild; Reutfors, Johan; Selmer, Randi Marie; Tomson, Torbjörn; Ulrichsen, Sinna Pilgaard; Zoega, Helga; Furu, Kari (Journal article; Peer reviewed, 2022)
      Objective: This study was undertaken to examine the comparative safety of antiseizure medication (ASM) monotherapy in pregnancy with respect to risk of major congenital malformations (MCMs), overall and by MCM subtype. ...

    • Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study 

      Graner, Sophie; Svensson, Tobias; Beau, Anna-Belle; Damase-Michel, Christine; Engeland, Anders; Furu, Kari; Hviid, Anders; Håberg, Siri Eldevik; Mølgaard-Nielsen, Ditte; Pasternak, Björn; Kieler, Helle (Peer reviewed; Journal article, 2017)
      Objective: To evaluate the possible effects of exposure to neuraminidase inhibitors during embryo-fetal life with respect to adverse neonatal outcomes and congenital malformations. Design: Population based multinational ...

    • Preeclampsia in pregnancy and later use of antihypertensive drugs 

      Engeland, Anders; Bjørge, Tone; Klungsøyr, Kari; Skjaerven, Rolv; Skurtveit, Svetlana; Furu, Kari (Peer reviewed; Journal article, 2015-03-18)
      We explored the association between preeclampsia and later use of antihypertensive drugs in a population-based study with data from the Medical Birth Registry of Norway and the Norwegian Prescription Database. The study ...

    • Prescribed drugs in 27 000 individuals after diagnosis of colorectal cancer: A population-based cohort study 

      Engeland, Anders; Ghaderi, Sara; dos-Santos-Silva, Isabel; Furu, Kari; Hjellvik, Vidar; Kvåle, Rune; Bjørge, Tone (Journal article; Peer reviewed, 2021)
      Background The prevalence of prescribed drugs in survivors of colorectal cancer (CRC) was evaluated. Methods Data from the Cancer Registry of Norway were linked to the Norwegian Prescription Database for a study ...

    • Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway 

      Engeland, Anders; Bjørge, Tone; Daltveit, Anne Kjersti; Skurtveit, Svetlana; Vangen, Siri; Vollset, Stein Emil; Furu, Kari (Peer reviewed; Journal article, 2011-02-06)
      This study aimed to use a population-based Prescription Database to explore later development of diabetes in women registered with gestational diabetes mellitus (GDM) and/or preeclampsia in the Medical Birth Registry of ...

    • Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: Population based cohort study and sibling design 

      Furu, Kari; Kieler, Helle; Haglund, Bengt; Engeland, Anders; Selmer, Randi; Stephansson, Olof; Valdimarsdottir, Unnur Anna; Zoega, Helga; Artama, Miia; Gissler, Mika; Malm, Heli; Nørgaard, Mette (Peer reviewed; Journal article, 2015)
      Objective To assess whether use of specific selective serotonin reuptake inhibitors (SSRIs) or venlafaxine in early pregnancy is associated with an increased risk of birth defects, with emphasis on cardiovascular birth ...

    • Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries 

      Kieler, Helle; Artama, Miia; Engeland, Anders; Ericsson, Örjan; Furu, Kari; Gissler, Mika; Nielsen, Rikke Beck; Nørgaard, Mette; Stephansson, Olof; Valdimarsdottir, Unnur; Zoega, Helga; Haglund, Bengt (Journal article, 2012-01-12)
      Objective: To assess whether maternal use of selective serotonin reuptake inhibitors (SSRIs) increases the risk of persistent pulmonary hypertension in the newborn, and whether such an effect might differ between specific ...

    • Use of antidepressants and association with elective termination of pregnancy: population based case-control study 

      Kieler, H; Malm, H; Artama, M; Engeland, Anders; Furu, Kari; Gissler, Mika; Nørgaard, M; Stephansson, Olof; Valdimarsdóttir, Unnur Anna; Zoega, H; Haglund, Bengt (Peer reviewed; Journal article, 2014-11-14)
      Objective To assess whether the use of selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, mirtazapine, venlafaxine or other antidepressants is associated with late elective termination of pregnancy. ...

    • Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia 

      Cesta, Carolyn E.; Segovia Chacón, Silvia; Engeland, Anders; Broe, Anne; Damkier, Per; Furu, Kari; Kieler, Helle; Karlsson, Pär (Journal article; Peer reviewed, 2021)
      Introduction For phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil, the only approved indication in women is for pulmonary arterial hypertension. These drugs are increasingly being proposed and tested for ...